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Abstract
Libman-Sacks endocarditis (LSE), characterized by verrucous vegetations formation, is a typical cardiac
manifestation of autoimmune diseases such as systemic lupus erythematosus (SLE) and antiphospholipid
syndrome (APS). It primarily leads to lesions of cardiac valves and mostly involved valves are mitral and
aortic, but isolated tricuspid valve involvement is exceptional. Here we reported a 20-years-old female with
past SLE history suffered from acute right heart failure caused by multiple tricuspid vegetations and valve
regurgitation. The patient recovered following tricuspid valve replacement with a bioprosthesis. Transesophageal
echocardiography(TEE), especially real time 3-dimensional (RT3D) TEE provide a better imaging modality for
assessing cardiac valvular involvement of LSE. For patients with active SLE/APS course,
uncontrolled systemic inflammation may made it difficult for surgical exposure and suture. The durability of
bioprosthesis for this patient and the prosthesis selection for tricuspid LSE both need further follow-up and more
clinical investigation.
Keywords: Endocarditis, Three dimesional transesophageal echocardiography, Tricuspid valve prosthesis, Tricuspid
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Background
In 1924, Libman and Sacks originally reported 4 sys-
temic lupus erythematosus (SLE) cases with verrucose
vegetative endocarditis [1], and that was the first intro-
duction of Libman-Sacks endocarditis(LSE). Nowadays,
LSE have been seen as a typical cardiac manifestation of
autoimmune diseases such as SLE and antiphospholipid
syndrome(APS). The pathologic changes of LSE involve
the formation of fibrin-platelet thrombi on the altered
valve, the organization of which leads to valve fibrosis,
edema, diffuse thickening, mild inflammatory changes,
valve distortion, scarring, and subsequent valvular dys-
function such like stenosis or regurgitation [2, 3]. LSE
often involve left heart valves, tricuspid lesions were
very rare. And most LSE can be treated with medicine
therapy while very few need surgical treatment. Here we
reported a rare tricuspid LSE patient with SLE history
which underwent open-heart surgery with bioprosthesis
replacement.
Case presentation
A 20-year-old young Asian female presented to our
department for continuous weakness and short of
breath for more than 2 months on June 2014. The
girl’s past history was significant for systemic lupus er-
ythematosus (SLE) more than 3 years but she denied
regular oral hormone therapy for nearly 2 years.
Symptoms of paroxysmal knee joint ache, paroxysmal
nocturnal dyspnea and orthopnea are manifested. She
had experienced increased dyspnea on exertion with
activities of daily living and increasing lower extremity
edema.
After admission the patient had transitional mild
fever with the highest temperature of 37.9 °C. Heart
auscultation showed systolic murmur at the 4th inter-
costal space by the left border of sternum. The trans-
thoracic and transesophageal echocardiography (TTE
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and TEE) showed severe tricuspid regurgitation and a
large single vegetation on the atrial surface of anterior
leaflet, which was swinged by blood flow. Real time3-
dimensional (RT3D)TEE further detected numerous
verrucose nodular thickening on the leaflet’s atrial sur-
face (Fig. 1). The computed tomography scan excluded
existence of arteritis. Her laboratory test yielded the
following: normal regular blood tests, elevated erythro-
cyte sedimentation rate and normal C-reactive protein
level, positive antinuclear antibody (tite 1:1000), de-
creased complement C3 and C4 levels(C3, 0.50 g/l; C4,
0.11 g/l), and negative anti-double-stranded DNA anti-
body, negative anticardiolipin antibody and negative
lupus anticoagulant. Hepatic and renal functions were
all normal just after admission. Blood culture was
taken for 3 times consecutively, but no existence of
bacteria was shown. History of unhygienic intravenous
injection was denied. Prednisone and hydroxychloro-
quine were given after admission for 2 weeks but the
valve vegetations didn’t disappear according to TEE
follow-ups, and the patient did show aggravated clin-
ical symptoms of right heart failure such as loss of ap-
petite, edema of lower extremities, polyserositis,
hepatolienomegaly and continuous increasing hepatic
function indexes.
Due to the uncontrolled and evolved right heart
failure, the patient received emergent surgery
intervention. Considering her uncontrolled SLE and
time-limited steroids treatment, the patient was in
status of uncontrolled systemic inflammatory re-
sponse, which leaded to acute pericarditis and peri-
cardial adhesion, also with edema of heart tissue. We
had spent more time to expose the heart and estab-
lish cardiopulmonary bypass. Intraoperative macro-
scopy showed a 5 mm*5 mm*5 mm vegetation
attached to the apex of tricuspid anterior leaflet, mul-
tiple verrucose nodular vegetations tightly adhered to
the leaflet and subvavular apparatus. The main chor-
dae tendinae of the leaflet was also ruptured due to
vegetation erosion (Fig. 2a–c). Due to the massive
vegetations and inflammation-induced tissue weak-
ness, a final decision of valve replacement was made
and a 31 mm Medtronic Hancock bioprosthesis was
implanted. The surgery and post-operation procedure
were both uneventful. The girl presented no symptom
of heart failure and discharged 1 weeks later but with
continuous follow-ups for heart surgery and further
prednisone treatment of SLE. Histopathological examin-
ation of the excised vegetation showed inflammation with
neutrophil infiltration combined with fibrin-platelet
thrombi formation (Fig. 2d–e). The patient was alive
3 months after surgery and echocardiogram follow-up
showed normal tricuspid bioprosthesis function without
regurgitation.
Discussion
The verrucous vegetations formation of LSE are seen as
a cardiac manifestation of SLE and/or APS. Mitral and
Fig. 1 Transesophgeal echocardiography images of the patient
before surgery. a Tricuspid regurgitation, Yellow arrowhead: wide
and reversed blood flow signals at TV site. b A large vegetation
formation. Yellow arrowhead: A large vegetation adhere to anterior
leaflet of TV. c Suspicious multiple vegetations on 3D echo image.
Yellow arrowheads: multiple verrucous abnormal nodular projections
on the leaflet surface. RA right atrium, RV right ventricle, LA left
atrium, LV left ventricle, TV tricuspid valve
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aortic valve is the mostly involved valve, while tricuspid
valve involvement was rarely reported. Moyssakis re-
ported 38 LSE in 342 SLE patient which were diagnosed
by echocardiography, among which there were 24 mitral
and 13 aortic involvement. only one tricuspid involve-
ment [4]. Doppler echocardiography can be considered
as the diagnostic technique of choice. But sometimes it
is very difficult to identify LSE and true infectious endo-
carditis (IE), for the former may also have fever due to
the original immunology diseases and the latter may also
have vegetation. Echocardiographically, LSE vegetations
appear as masses of varying size and shape with irregular
borders and heterogeneous echo-density, which are
firmly attached to the leaflet surface and exhibit no
independent motion [2]. While the vegetation of IE may
typically exhibit independent motion [5]. The role of
transesophageal echocardiography (TEE), especially
RT3D TEE, had been emphasized in assessing vegeta-
tion size in a patient with LSE [6]. And in our case the
diagnostic role of RT3D TEE had been also
highlighted, which might be more sensitive to the very
special verrucous vegetations.
Treatment for LSE consists of drug treatment and
surgical intervention. Corticosteroid and anticoagula-
tion drugs are used for LSE drug treatment. Cortico-
steroids cannot prevent LSE, but they can help healing
LSE lesions by lessening inflammation [3, 7, 8]. How-
ever they can also increase tissue fibrosis and scarring,
Fig. 2 Macroscopy and microscopy of the involved tricuspid valve and vegetation. a Yellow arrowhead: The large vegetation, Blue arrowhead:
rupture mainchordae tendinae. b Blue arrowheads: Multiple verrucous nodular vegetation on the atrial surface of leaflet. c Resected tricuspid
valve. Blue arrowheads: multiple small vegeatations, Yellow arrowhead: rupture main chordae tendinae. d microscopy of the vegetation adhered
to the leaflet, Magnification 4×, Hematoxylin and Eosin stain. e enlarged square area in (e) showing inflammatory cell infiltration and fibrin-
platelet thrombi, Magnification 20×, Hematoxylin and Eosin stain
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finally worsening valvular damage and dysfunction.
Nonetheless, appropriate and sufficient steroid therapy
to control autoimmune disease activity is important.
Anticoagulation therapy is required due to the in-
creased risk of thrombo-embolic events in LSE and
current therapeutic guidelines for APS did suggest
long-term anticoagulation to prevent thrombo-embolic
events [2, 3]. So if the patient with LSE is
hemodynamically stable, conservative treatments above
should be firstly recommended. Moaref had reported a
successfully recovered case of LSE with treatment of
prednisolone and hydroxychloroquine, but the patient
denied worsening symptoms of heart failure and re-
ceived drug treatments by months [9]. If with severe
intractable symptomatic valvular dysfunction, surgical
intervention for LSE may be required [10, 11]. Since
our patient got symptoms of acute uncontrolled right
heart failure, early surgical intervention even without
adequate steroid treatment should be considered.
In the past decade, large studies on the surgical treat-
ment for LSE were mostly focused on patients with
mitral LSE. Bouma et al. reviewed the English litera-
tures of surgical treatment for mitral regurgitation
caused by LSE and from 1974 to 2010 there were 41
patients with LSE undergoing mitral valve surgery re-
ported in 30 literatures, 13 patients underwent mitral
valve repair while 28 underwent replacement [12]. He
suggested that for only localized abnormalities with
otherwise relatively normal leaflets, repair and rather
than replacement was considered as a good surgical
opinion. We think the suggestion for mitral site also
partly works for tricuspid-involved patient. And we
had also reviewed the very few published cases of iso-
lated tricuspid LSE which underwent surgery, and col-
lected types of etiology and surgical procedure of
reported cases [13–18] (Table 1). Cases which exhib-
ited vegetations to obstruct valve orifice have the pos-
sibility of being treated by vegetation removal and may
not need valve replacement. While cases with subvavu-
lar apparatus involvement were mainly undergone
valve replacement. Wang had recently reported a 40-
year-old Asian female with SLE which had similarly
multiple vegetations on the subvalvular apparatus and
the atrial side of the leaflets of tricuspid valve and a
small perforation on a septal leaflet [13]. The patient
received sufficient steroid treatment but vegetations
still existed and finally underwent mechanical valve re-
placement due to the difficulty of vegetation removal.
We think if subvalvular apparatus were involved, the
repair work may be hard and choice of replacement
should be considered since the difficulty to reconstruct
the subvalvular apparatus (either vegetation removal
or repair of chordae tendinae, especially for active
SLE/APS patients which suffered total systemic
inflammation and tissue edema). In our case we also
judged the difficulty of repair due to multiple vegeta-
tions formation on the subvalvular apparatus and
inflammation-induced tissue weakness which leaded to
chordae rupture, finally implanted a Medtronic Han-
cock porcine bioprosthesis at the tricuspid site.
Usually for LSE, it was not very recommended to im-
plant a bioprosthesis since there was reported cases that
underwent re-operation in the future, due to rapid calci-
fication, valvulitis and subsequent perforation [19] or
massive bioprosthetic thrombosis [20]. So a mechanical
prosthesis might provide a comprehensive better result
for LSE. But there were no expert suggestion on pros-
thesis selection for tricuspid site for LSE. For normal
consideration, mechanical tricuspid valve replacement
(TVR) leads to increased early mortality [21] and occur-
rence of valve-related events, especially the composite of
thrombosis, embolism, and bleeding [22]. Compared to
the possibility of mid-to-long-term degeneration and
failure of bioprosthesis, we could not tell which kind of
prosthesis on tricuspid site should have better outcomes.
Considering the prosthesis site and the gender/age of
our patient, a mechanical valve may be not very recom-
mended since it might need more intense anticoagula-
tion at tricuspid site which may lead to unexpected
embolism-bleeding events and bring harassments for fe-
male menstruation and pregnancy. But the durability of
bioprosthesis for this patient and the prosthesis selection
for tricuspid LSE both need further follow-up and more
clinical investigation.
Conclusion
LSE should be strongly suspected when significant valve
vegeation unveiled during the course of SLE and/or
APS. Mitral involvement is common but tricuspid LSE is
rarely reported. TEE, especially RT3D-TEE, is useful for
diagnosis between LSE and IE. Conservative treatment
with steroids should be firstly recommended, but pa-
tients with untreated and severe intractable symptomatic
valvular dysfunction still need surgical intervention. For
patients with active SLE/APS course, uncontrolled sys-
temic inflammation may made it difficult for surgical ex-
posure and suture. The prosthesis selection for tricuspid
LSE when valve repair is impossible, mechanical or bio-
prothesis, need further follow-ups and more clinical
cases investigation.
Consent
Written informed consent was obtained from the patient
for publication of this case report and any accompanying
images. A copy of the written consent is available for re-
view by the Editor-in-Chief of this journal.
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Morphological changes Surgical procedure Follow-up






Ledingham et al. [15]a 1988 F/19 SLE No TS a large calcified mass invading
the right side of the heart
Bioprosthesis replacement
TS Subsequent tricuspid stenosisafter initial
surgery




Chan-Lam et al. [16]a 2001 F/29 APS TS two masses that were adherent
to the tricuspid valve and
intermittently prolapsed
through the pulmonary valve.
Surgical removal of the masses
Falode et al. [17] 2006 F/35 APS Not mentioned Yes TS massive vegetations involving
the tricuspid valve, filling the
right atrium
Vegetation removal and valve





Gur et al. [18] 2014 F/20 SLE Yes Yes TS multiple verrucous vegetations
as if being a mass on the






Wang et al. [13] 2014 F/40 SLE Yes No TR several large nodules on the
subvalvular apparatus and the
atrial side of the leaflets of
tricuspid valve; small
perforation on a septal leaflet
Mechanical valve replacement Alive 5 weeks
post-op
Bai et al. 2014 F/20 SLE No Yes TR A large and mutiple tiny
vegetations on the atrial side
of anterior leaflet with ruptured




TS Tricuspid stenosis, TR Tricuspid Regurgitation
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